CME Group (NASDAQ:CME) Price Target Cut to $310.00 by Analysts at Raymond James Financial

CME Group (NASDAQ:CME) had its price target trimmed by Raymond James Financial from $311.00 to $310.00 in a research note issued to investors on Wednesday,MarketScreener reports. The firm currently has an outperform rating on the financial services provider’s stock.

Several other research firms have also recently weighed in on CME. TD Cowen boosted their price target on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday. Barclays upped their target price on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a report on Thursday. Royal Bank Of Canada lifted their price target on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a report on Thursday. Keefe, Bruyette & Woods upped their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Finally, The Goldman Sachs Group decreased their target price on CME Group from $265.00 to $264.00 and set a “sell” rating for the company in a research report on Wednesday, January 14th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $295.82.

CME Group Stock Up 0.9%

CME traded up $2.76 during midday trading on Wednesday, reaching $297.38. 2,496,468 shares of the company were exchanged, compared to its average volume of 2,170,406. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company’s fifty day moving average price is $276.15 and its 200 day moving average price is $272.67. The company has a market cap of $107.24 billion, a price-to-earnings ratio of 28.82, a price-to-earnings-growth ratio of 3.30 and a beta of 0.27. CME Group has a one year low of $239.70 and a one year high of $302.20.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the company earned $2.52 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. As a group, analysts expect that CME Group will post 10.49 EPS for the current year.

Insider Transactions at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William R. Shepard bought 251 shares of the stock in a transaction dated Tuesday, December 30th. The stock was bought at an average cost of $278.37 per share, with a total value of $69,870.87. Following the purchase, the director owned 258,710 shares in the company, valued at $72,017,102.70. The trade was a 0.10% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. Caldwell Trust Co lifted its position in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 50 shares during the period. Asset Dedication LLC lifted its holdings in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in shares of CME Group during the 3rd quarter worth approximately $27,000. FNY Investment Advisers LLC bought a new position in shares of CME Group in the 4th quarter worth approximately $27,000. Finally, Financial Consulate Inc. bought a new stake in shares of CME Group during the third quarter valued at approximately $28,000. Institutional investors own 87.75% of the company’s stock.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results beat: CME reported $2.77 EPS and $1.65B revenue, beating estimates and showing ADV growth and higher clearing fees — supports near‑term earnings momentum. PR Newswire: Q4 Results
• Positive Sentiment: Record trading/ADV lift: Management highlighted all‑time high ADV for any Q4, driving revenue and profit leverage — a structural UX tailwind for fee and clearing income. Investor’s Business Daily
• Positive Sentiment: Analyst support — Morgan Stanley maintained a Buy/Overweight rating, citing defensive, fee‑based franchise and underappreciated structural growth. That helps demand for the name. TipRanks / Morgan Stanley note
• Neutral Sentiment: RBC raised its price target to $302 (keeps sector perform) — a modest positive signal but not a strong upgrade; reinforces mixed analyst view. MarketScreener: RBC raise
• Neutral Sentiment: Management initiatives: CEO Duffy said CME is exploring a CME‑issued token and piloting tokenized cash with Google to enable faster collateral movement — strategic optionality but execution and regulatory timing are uncertain. Cointelegraph: Token exploration
• Neutral Sentiment: Fee adjustments & product expansion: Management expects a 1%–1.5% revenue lift from fee changes and is expanding 24/7 crypto and securities clearing — positive medium‑term levers but gradual impact. MSN: Fee changes & expansion
• Negative Sentiment: Small downward PT tweak: Raymond James trimmed its target from $311 to $310 while keeping an Outperform rating — a minor negative on optics but little change to the bullish stance. MarketScreener: Raymond James PT change

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.